{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:56:15Z","timestamp":1790787375115,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1124\/jpet.112.197665","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T06:32:32Z","timestamp":1347949952000},"page":"746-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Orally Active Glutamate Carboxypeptidase II Inhibitor E2072 Exhibits Sustained Nerve Exposure and Attenuates Peripheral Neuropathy"],"prefix":"10.1016","volume":"343","author":[{"given":"Krystyna M.","family":"Wozniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Vornov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Lapidus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Rais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Slusher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.197665_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1744-8069-6-60","article-title":"N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity\/transmission in the amygdala in a mouse inflammatory pain model","volume":"6","author":"Adedoyin","year":"2010","journal-title":"Mol Pain"},{"key":"10.1124\/jpet.112.197665_bib2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2174\/092986712799034888","article-title":"Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer","volume":"19","author":"Ba\u0159inka","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1124\/jpet.112.197665_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1124\/jpet.112.197665_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.npp.1300559","article-title":"NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons","volume":"30","author":"Bergeron","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.112.197665_bib5","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1523\/JNEUROSCI.18-23-09594.1998","article-title":"Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-\u03b2","volume":"18","author":"Bruno","year":"1998","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.112.197665_bib6","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1471-4159.1987.tb01030.x","article-title":"N-acetylaspartylglutamate in spinal sensory ganglia","volume":"49","author":"Cangro","year":"1987","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.112.197665_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0306-4522(01)00238-X","article-title":"Localization of metabotropic glutamate receptors 2\/3 on primary afferent axons in the rat","volume":"105","author":"Carlton","year":"2001","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.112.197665_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1469-7580.2008.00984.x","article-title":"Expression and distribution of \u2018high affinity\u2019 glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system","volume":"213","author":"Carozzi","year":"2008","journal-title":"J Anat"},{"key":"10.1124\/jpet.112.197665_bib9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12640-009-9114-1","article-title":"Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat","volume":"17","author":"Carozzi","year":"2010","journal-title":"Neurotox Res"},{"key":"10.1124\/jpet.112.197665_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.npep.2003.08.001","article-title":"Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat","volume":"37","author":"Carpenter","year":"2003","journal-title":"Neuropeptides"},{"key":"10.1124\/jpet.112.197665_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1517\/14740338.3.6.535","article-title":"Chemotherapy-induced peripheral neurotoxicity","volume":"3","author":"Cavaletti","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"10.1124\/jpet.112.197665_bib12","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1124\/jpet.300.2.662","article-title":"Effect of 2-(phosphono-methyl)-pentanedioic acid on allodynia and afferent ectopic discharges in a rat model of neuropathic pain","volume":"300","author":"Chen","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.197665_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/nbdi.1997.0153","article-title":"N-acetylaspartylglutamate","volume":"4","author":"Coyle","year":"1997","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.112.197665_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"key":"10.1124\/jpet.112.197665_bib15","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1016\/0006-2952(84)90138-2","article-title":"Captopril disulfide conjugates may act as prodrugs: disposition of the disulfide dimer of captopril in the rat","volume":"33","author":"Drummer","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.112.197665_bib16","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.1073\/pnas.1530168100","article-title":"Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models","volume":"100","author":"Ghadge","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.112.197665_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.npp.1300304","article-title":"Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia","volume":"29","author":"Ghose","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.112.197665_bib18","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1172\/JCI1130","article-title":"Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle","volume":"101","author":"Gill","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.112.197665_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ab.2011.04.013","article-title":"N-ethylmaleimide","volume":"415","author":"Giustarini","year":"2011","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.112.197665_bib20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.schres.2007.11.013","article-title":"Dysregulation of glutamate carboxypeptidase II in psychiatric disease","volume":"99","author":"Guilarte","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1124\/jpet.112.197665_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1124\/jpet.112.197665_bib22","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/jpet.112.197665_bib23","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1021\/jm0001774","article-title":"Design and pharmacological activity of phosphinic acid based NAALADase inhibitors","volume":"44","author":"Jackson","year":"2001","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.112.197665_bib24","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1021\/jm0306226","article-title":"Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents","volume":"47","author":"Kozikowski","year":"2004","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.112.197665_bib25","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nm.2231","article-title":"Central mechanisms of pathological pain","volume":"16","author":"Kuner","year":"2010","journal-title":"Nat Med"},{"key":"10.1124\/jpet.112.197665_bib26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","article-title":"Glutamate receptors, neurotoxicity and neurodegeneration","volume":"460","author":"Lau","year":"2010","journal-title":"Pflugers Arch"},{"key":"10.1124\/jpet.112.197665_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2004.12.008","article-title":"Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats","volume":"508","author":"Long","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.197665_bib28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.neuropharm.2003.10.007","article-title":"NAAG fails to antagonize synaptic and extrasynaptic NMDA receptors in cerebellar granule neurons","volume":"46","author":"Losi","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.112.197665_bib29","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1021\/jm051019l","article-title":"Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1\u2032 side chain","volume":"49","author":"Majer","year":"2006","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.112.197665_bib30","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1021\/jm020515w","article-title":"Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor","volume":"46","author":"Majer","year":"2003","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.112.197665_bib31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0006-8993(92)91276-K","article-title":"Genetically epilepsy-prone rats have increased brain regional activity of an enzyme which liberates glutamate from N-acetyl-aspartyl-glutamate","volume":"593","author":"Meyerhoff","year":"1992","journal-title":"Brain Res"},{"key":"10.1124\/jpet.112.197665_bib32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.neuropharm.2006.07.018","article-title":"Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain\u2013relation to brain concentration","volume":"51","author":"Nagel","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.112.197665_bib33","first-page":"477","article-title":"N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia","volume":"26","author":"Neale","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.112.197665_bib34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1471-4159.2011.07338.x","article-title":"Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family","volume":"118","author":"Neale","year":"2011","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.112.197665_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1073858403261077","article-title":"The amygdala and persistent pain","volume":"10","author":"Neugebauer","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1124\/jpet.112.197665_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.brainres.2007.01.112","article-title":"Selective vulnerability of hippocampal NAAGergic neurons in experimental temporal lobe epilepsy","volume":"1144","author":"Pacheco Otalora","year":"2007","journal-title":"Brain Res"},{"key":"10.1124\/jpet.112.197665_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02815236","article-title":"N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated \u03b1-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases","volume":"31","author":"Passani","year":"1997","journal-title":"Mol Chem Neuropathol"},{"key":"10.1124\/jpet.112.197665_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF03191310","article-title":"d-penicillamine in the DA-strain rat","volume":"13","author":"Pilkington","year":"1988","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1124\/jpet.112.197665_bib39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0361-9230(93)90269-H","article-title":"N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in amyotrophic lateral sclerosis","volume":"30","author":"Plaitakis","year":"1993","journal-title":"Brain Res Bull"},{"key":"10.1124\/jpet.112.197665_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00213-011-2200-0","article-title":"Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia","volume":"216","author":"Profaci","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.112.197665_bib41","doi-asserted-by":"crossref","unstructured":"Rais R, Hoover R, Wozniak K, Rudek M, Tsukamoto T, Alt J, Rojas C, Slusher BS (2012) Reversible disulfide formation of the GCP-II inhibitor E2072 results in prolonged systemic exposures in vivo. Drug Metab Dispos http:\/\/dx.doi.org\/10.1124\/dmd.112.046821.","DOI":"10.1124\/dmd.112.046821"},{"key":"10.1124\/jpet.112.197665_bib42","doi-asserted-by":"crossref","first-page":"14498","DOI":"10.1016\/S0021-9258(18)47823-4","article-title":"N-acetyl-l-aspartyl-l-glutamate. Identification and characterization of a novel N-acetylated \u03b1-linked acidic dipeptidase activity from rat brain","volume":"262","author":"Robinson","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.197665_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0003-2697(02)00286-5","article-title":"Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay","volume":"310","author":"Rojas","year":"2002","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.112.197665_bib44","first-page":"41","article-title":"Experimental evaluation of potential anticancer agents. 28. Effects of therapy on viability and rate of proliferation of leukemic cells in various anatomic sites","volume":"47","author":"Skipper","year":"1965","journal-title":"Cancer Chemother Rep"},{"key":"10.1124\/jpet.112.197665_bib45","doi-asserted-by":"crossref","first-page":"21297","DOI":"10.1016\/S0021-9258(17)45359-2","article-title":"Rat brain N-acetylated \u03b1-linked acidic dipeptidase activity. Purification and immunologic characterization","volume":"265","author":"Slusher","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.197665_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/cne.903150208","article-title":"N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated \u03b1-linked acidic dipeptidase (NAALADase)","volume":"315","author":"Slusher","year":"1992","journal-title":"J Comp Neurol"},{"key":"10.1124\/jpet.112.197665_bib47","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/70971","article-title":"Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury","volume":"5","author":"Slusher","year":"1999","journal-title":"Nat Med"},{"key":"10.1124\/jpet.112.197665_bib48","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/jm300488m","article-title":"Design, synthesis, and pharmacological evaluation of glutamate carboxypeptidase II (GCPII) inhibitors based on thioalkylbenzoic acid scaffolds","volume":"55","author":"Stoermer","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.112.197665_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(01)01239-0","article-title":"Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-\u03b2","volume":"430","author":"Thomas","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.197665_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(91)90560-I","article-title":"N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS","volume":"556","author":"Tsai","year":"1991","journal-title":"Brain Res"},{"key":"10.1124\/jpet.112.197665_bib51","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.drudis.2007.07.010","article-title":"Progress in the discovery and development of glutamate carboxypeptidase II inhibitors","volume":"12","author":"Tsukamoto","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.112.197665_bib52","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2005.05.049","article-title":"Spinal glial glutamate transporters downregulate in rats with taxol-induced hyperalgesia","volume":"386","author":"Weng","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.112.197665_bib53","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1158\/0008-5472.CAN-10-4184","article-title":"Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice","volume":"71","author":"Wozniak","year":"2011","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.112.197665_bib54","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2174\/092986712799462630","article-title":"The role of glutamate signaling in pain processes and its regulation by GCP II inhibition","volume":"19","author":"Wozniak","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1124\/jpet.112.197665_bib55","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1471-4159.1997.69010174.x","article-title":"N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells","volume":"69","author":"Wroblewska","year":"1997","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.112.197665_bib56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1460-9568.2004.03504.x","article-title":"N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model","volume":"20","author":"Yamamoto","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.112.197665_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1744-8069-4-31","article-title":"N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain","volume":"4","author":"Yamamoto","year":"2008","journal-title":"Mol Pain"},{"key":"10.1124\/jpet.112.197665_bib58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0006-8993(01)02650-6","article-title":"N-acetyl-\u03b1-linked acidic dipeptidase (NAALADase) inhibition attenuates mechanical allodynia induced by paw carrageenan injection in the rat","volume":"909","author":"Yamamoto","year":"2001","journal-title":"Brain Res"},{"key":"10.1124\/jpet.112.197665_bib59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1460-9568.2006.05272.x","article-title":"N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats","volume":"25","author":"Yamamoto","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.112.197665_bib60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jns.2006.05.052","article-title":"The preventive and therapeutic effects of GCPII (NAALADase) inhibition on painful and sensory diabetic neuropathy","volume":"247","author":"Zhang","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1124\/jpet.112.197665_bib61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-510X(01)00670-0","article-title":"GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB\/Wor rats","volume":"194","author":"Zhang","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1124\/jpet.112.197665_bib62","doi-asserted-by":"crossref","first-page":"21773","DOI":"10.1074\/jbc.M112.363226","article-title":"N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia","volume":"287","author":"Zuo","year":"2012","journal-title":"J Biol Chem"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524184479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524184479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.197665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:16:38Z","timestamp":1739985398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524184479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0022356524184479"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.197665","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Orally Active Glutamate Carboxypeptidase II Inhibitor E2072 Exhibits Sustained Nerve Exposure and Attenuates Peripheral Neuropathy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.197665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}